Skip to main content
SpringerLink
Log in

Negative Impact of Blood Transfusion on Recurrence and Prognosis of Hepatocellular Carcinoma After Hepatic Resection

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

In perioperative management of hepatic resection for hepatocellular carcinoma, excessive blood loss and blood transfusion greatly influence postoperative complications and prognosis of the patients. We evaluated the influence of blood products use on postoperative recurrence and prognosis of patients with hepatocellular carcinoma.

Methods

The subjects were 66 patients who underwent elective hepatic resection for hepatocellular carcinoma without concomitant microwave or radiofrequency ablation therapy nor other malignancies between January 2001 and June 2006. We retrospectively investigated the influence of the use of blood products including red cell concentration and fresh frozen plasma on recurrence of hepatocellular carcinoma and overall survival.

Results

In multivariate analysis, the dose of blood products transfusion was a significant predictor of disease-free and overall survival. Both disease-free and overall survival rates of those who were given blood products were significantly worse than those who did not receive. On the other hand, in univariate analysis of disease-free and overall survival after hepatic resection and clinical variables, the amount of blood loss was not a significant predictor of recurrence or death.

Conclusion

Transfusion of blood products is associated with increased recurrence rate and worse survival after elective hepatic resection for patients with hepatocellular carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

References

  1. Sugioka A, Tsuzuki T, Kanai T. Postresection prognosis of patients with hepatocellular carcinoma. Surgery 1993;113:612–618.

    PubMed  CAS  Google Scholar 

  2. Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, Fujimoto J, Oriyama T, Furukawa K, Kawamura E. Prognostic factors after hepatectomy for hepatocellular carcinomas. Cancer 1990;65:1104–1110.

    Article  PubMed  CAS  Google Scholar 

  3. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, Wong J. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63–70.

    Article  PubMed  CAS  Google Scholar 

  4. Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995;19:35–41.

    Article  PubMed  CAS  Google Scholar 

  5. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790–800.

    Article  PubMed  CAS  Google Scholar 

  6. Chen MF, Hwang TL, Jeng LB, Jan YY, Wang CS, Chou FF. Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg 1989;124:1025–1028.

    PubMed  CAS  Google Scholar 

  7. Nagao T, Inoue S, Yoshimi F, Sodeyama M, Omori Y, Mizuta T, Kawano N, Morioka Y. Postoperative recurrence of hepatocellilar carcinoma. Ann Surg 1990;211:28–33.

    Article  PubMed  CAS  Google Scholar 

  8. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, Chang YC, Kohno H, Nakamura T, Yukaya H. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993;105:488–494.

    PubMed  CAS  Google Scholar 

  9. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114–117.

    Article  PubMed  CAS  Google Scholar 

  10. Yanaga K, Okudaira S, Kanematsu T, Marsh JW. Hepatic Resection for Hepatocellular Carcinoma. In Carr B, ed. Hepatocellular Cancer: Diagnosis and Treatment. Totowa: Humana Press, 2005, pp 185–198.

    Chapter  Google Scholar 

  11. Brunson ME, Alexander JW. Mechanisms of transfusion-induced immunosuppression. Transfusion 1990;30:651–658.

    Article  PubMed  CAS  Google Scholar 

  12. Blajchman MA, Bordin JO. Mechanisms of transfusion-associated immunosuppression. Curr Opin Hematol 1994;1:457–461.

    PubMed  CAS  Google Scholar 

  13. Blajchman MA. Immunomodulation and blood transfusion. Am J Ther 2002;9:389–395.

    Article  PubMed  Google Scholar 

  14. Magee CC, Sayegh MH. Peptide-mediated immunosuppression. Curr Opin Immunol 1997;9:669–675.

    Article  PubMed  CAS  Google Scholar 

  15. Krensky AM, Clayberger C. Structure of HLA molecules and immunosuppressive effects of HLA derived peptides. Int Rev Immunol 1996;13:173–185.

    Article  PubMed  CAS  Google Scholar 

  16. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Mizuno S, Makuuchi M. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994;115:303–309.

    PubMed  CAS  Google Scholar 

  17. Yanaga K, Kanematsu T, Takenaka K, Matsumata T, Yoshida Y, Sugimachi K. Hepatic resection for hepatocellular carcinoma in elderly patients. Am J Surg 1988;155:238–241.

    Article  PubMed  CAS  Google Scholar 

  18. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N, Morioka Y. Hepatic resection for hepatocellular carcinoma: clinical features and long-term prognosis. Ann Surg 1987;205:22–40.

    Article  Google Scholar 

  19. Asahara T, Katayama K, Itamoto T, Yano M, Hino H, Okamoto Y, Nakahara H, Dohi K, Moriwaki K, Yuge O. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 1999;23:676–680.

    Article  PubMed  CAS  Google Scholar 

  20. Tralhao JG, Kayal S, Dagher I, Sanhueza M, Vons C, Franco D. Resection of hepatocellular carcinoma: the effect of surgical margin and blood transfusion on long-term survival. Analysis of 209 consecutive patients. Hepatogastroenterology 2007;54:1200–1206.

    PubMed  CAS  Google Scholar 

  21. Sugita S, Sasaki A, Iwaki K, Uchida H, Kai S, Shibata K, Ohta M, Kitano S. Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intra-operative allogenic blood transfusion: a retrospective study. Eur J Surg Oncol 2008;34:339–345.

    PubMed  CAS  Google Scholar 

  22. Foster RS, Costanza MC, Foster JC, Wanner MC, Foster CB. Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer 1985;55:1195–1201.

    Article  PubMed  Google Scholar 

  23. Younes RN, Rogatko A, Brennan MF. The influence of intra-operative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 1991;214:107–113.

    Article  PubMed  CAS  Google Scholar 

  24. Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992;216:633–638.

    Article  PubMed  CAS  Google Scholar 

  25. Parrott NR, Lennard TW, Taylor RM, Proud G, Shenton BK, Johnston ID. Effect of perioperative blood transfusion on recurrence of colorectal cancer. Br J Surg 1986;73:970–973.

    Article  PubMed  CAS  Google Scholar 

  26. Blumberg N, Agarwal MM, Chuang C. Relation between recurrence of cancer of the colon and blood transfusion. Br Med J 1985;290:1037–1039.

    Article  CAS  Google Scholar 

  27. Stephenson KR, Steinberg SM, Hughes KS, Vetto JT, Sugarbaker PH, Chang AE. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg 1988;208:679–687.

    Article  PubMed  CAS  Google Scholar 

  28. Little AG, Wu HS, Ferguson MK, Ho CH, Bowers VD, Segalin A, Staszek VM. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg 1990;160:630–632.

    Article  PubMed  CAS  Google Scholar 

  29. Tartter PI, Burrows L, Kirschner P. Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset N0) non-oat cell lung cancer. J Thorac Cardiovasc Surg 1984;88:659–662.

    PubMed  CAS  Google Scholar 

  30. Hyman NH, Foster RS, DeMeules JE, Costanza MC. Blood transfusions and survival after lung cancer resection. Am J Surg 1985;149:502–507.

    Article  PubMed  CAS  Google Scholar 

  31. Moores DW, Piantadosi S, McKneally MF. Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Ann Thorac Surg 1989;47:346–351.

    Article  PubMed  CAS  Google Scholar 

  32. Crowe JP, Gordon NH, Fry DE, Shuck JM, Hubay CA. Breast cancer survival and perioperative blood transfusion. Surgery 1989;106:836–841.

    PubMed  CAS  Google Scholar 

  33. Nowak MM, Ponsky JL. Blood transfusion and disease-free survival in carcinoma of the breast. J Surg Oncol. 1984;27:124–130.

    Article  PubMed  CAS  Google Scholar 

  34. Kaneda M, Horimi T, Ninomiya M, Nagae M, Mukai K, Takeda I, Shimoyama H, Chohno S, Okabayashi T, Kagawa S. Adverse affect of blood transfusions on survival of patients with gastric cancer. Transfusion 1987;27:375–377.

    Article  PubMed  CAS  Google Scholar 

  35. Fong Y, Karpeh M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994;167:256–260.

    Article  PubMed  CAS  Google Scholar 

  36. Shiba H, Ishii Y, Ishida Y, Wakiyama S, Sakamoto T, Ito R, Gocho T, Uwagawa T, Hirohara S, Kita Y, Misawa T, Yanaga K. Assessment of blood products use as predictors of pulmonary complications and surgical site infection after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2009;16:69–74.

    Article  PubMed  Google Scholar 

  37. Vamvakas EC, Carven JH. Exposure to allogeneic plasma and risk of postoperative pneumonia and/or infection in coronary artery bypass graft surgery. Transfusion 2002;42:107–113.

    Article  PubMed  Google Scholar 

  38. Matsumata T, Ikeda Y, Hayashi H, Kamakura T, Taketomi A, Sugimachi K. The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinoma. Cancer 1993;72:1866–1871.

    Article  PubMed  CAS  Google Scholar 

  39. Kwon AH, Matsui Y, Kamiyama Y. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer 2001;91:771–778.

    Article  PubMed  CAS  Google Scholar 

  40. Yamamoto J, Kosuge T, Saiura A, Sakamoto Y, Shimada K, Sano T, Takayama T, Sugawara Y, Yamaguchi T, Kokudo N, Makuuchi M. Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria. Jpn J Clin Oncol 2007;37:287–295.

    Article  PubMed  Google Scholar 

  41. Zhou L, Rui JA, Wang SB, Chen SG, Qu Q, Chi TY, Wei X, Han K, Zhang N, Zhao HT. Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy. World J Surg 2007;31:1782–1787.

    Article  PubMed  Google Scholar 

  42. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg 1995;169:589–594.

    Article  PubMed  CAS  Google Scholar 

  43. Bureau of Medicinal Safety, Ministry of Health and Welfare. Guidelines for administering blood preparations. Medical and Pharmaceutical Notification No. 715, June 10, 1999

  44. Ueno S, Tanabe G, Nuruki K, Hamanoue M, Komorizono Y, Oketani M, Hokotate H, Inoue H, Baba Y, Imamura Y, Aikou T. Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis. Hepatol Res 2002;24:395–403.

    Article  PubMed  Google Scholar 

  45. Weiden PL, Bean MA, Schultz P. Perioperative blood transfusion does not increase the risk of colorectal cancer recurrence. Cancer 1987;60:870–874.

    Article  PubMed  CAS  Google Scholar 

  46. Keller SM, Groshen S, Martini N, Kaiser LR. Blood transfusion and lung cancer recurrence. Cancer 1988;62:606–610.

    Article  PubMed  CAS  Google Scholar 

  47. Foster RS, Foster JC, Costanza MC. Blood transfusions and survival after surgery for breast cancer. Arch Surg 1984;119:1138–1140.

    PubMed  Google Scholar 

  48. Voogt PJ, van de Velde CJ, Brand A, Hermans J, Stijnen T, Bloem R, Leer JW, Zwaveling A, van Rood JJ. Perioperative blood transfusion and cancer prognosis: different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer 1987;59:836–843.

    Article  PubMed  CAS  Google Scholar 

  49. Eickhoff JH, Andersen J, Laybourn C. Perioperative blood transfusion does not promote recurrence and death after mastectomy for breast cancer. The Danish Breast Cancer Cooperative Group. Br J Surg 1991;78:1358–1361.

    Article  PubMed  CAS  Google Scholar 

  50. van de Watering LM, Brand A, Houbiers JG, Klein Kranenbarg WM, Hermans J, van de Velde C. Cancer Recurrence and Blood Transfusion Study Group. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. Br J Surg 2001;88:267–272.

    Article  PubMed  Google Scholar 

  51. Fan ST, Ng IO, Poon RT, Lo CM, Liu CL, Wong J. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg 1999;134:1124–1130.

    Article  PubMed  CAS  Google Scholar 

  52. de Boer MT, Molenaar IQ, Porte RJ. Impact of blood loss on outcome after liver resection. Dig Surg 2007;24:259–264.

    Article  PubMed  Google Scholar 

  53. Fujimoto J, Okamoto E, Yamanaka N, Tanaka T, Tanaka W. Adverse effect of perioperative blood transfusions on survival after hepatic resection for hepatocellular carcinoma. Hepatogastroenterology 1997;44:1390–1396.

    PubMed  CAS  Google Scholar 

  54. Hsu HC, Wu TT, Wu MZ, Wu CY, Chiou TJ, Sheu JC, Lee CS, Chen DS. Evolution of expression of hepatitis B surface and core antigens (HBsAg, HBcAg) in resected primary and recurrent hepatocellular carcinoma in HBsAg carriers in Taiwan: correlation with local host immune response. Cancer 1988;62:915–921.

    Article  PubMed  CAS  Google Scholar 

  55. Yamasaki H, Okamoto E, Komatsu T, Manabe Y, Shinka S. Relationship between general or specific immunoreactivity and prognosis in postoperative patients with hepatocellular carcinoma. Cancer Immunol Immunother 1990;31:107–114.

    Article  PubMed  CAS  Google Scholar 

  56. Ayers RC, Robertson DA, Dewbury KC, Millward-Sadler GH, Smith CL. Spontaneous regression of hepatocellular carcinoma. Gut 1990;31:722–724.

    Article  Google Scholar 

  57. Suzuki M, Okazaki N, Yoshino M, Yoshida T. Spontaneous regression of a hepatocellular carcinoma: a case report. Hepatogastroenterology 1989;36:160–163.

    PubMed  CAS  Google Scholar 

  58. Sato Y, Fujiwara K, Nakagawa S, Kanishima S, Ohta Y, Oka Y, Hayashi S, Oka H. A case of spontaneous regression of hepatocellular carcinoma with bone metastasis. Cancer 1985;56:667–671.

    Article  PubMed  CAS  Google Scholar 

  59. Ohta H, Sakamoto Y, Ojima H, Yamada Y, Hibi T, Takahashi Y, Sano T, Shimada K, Kosuge T. Spontaneous regression of hepatocellular carcinoma with complete necrosis: case report. Abdom Imaging 2005;30:734–737.

    Article  PubMed  CAS  Google Scholar 

  60. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305–1308.

    Article  PubMed  CAS  Google Scholar 

  61. Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998;396:699–703.

    Article  PubMed  CAS  Google Scholar 

  62. Ghio M, Contini P, Mazzei C, Brenci S, Barberis G, Filaci G, Indiveri F, Puppo F. Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immnomodulatory effects of allogeneic blood transfusions. Blood 1999;93:1770–1777.

    PubMed  CAS  Google Scholar 

  63. Puppo F, Contini P, Ghio M, Brenci S, Scudeletti M, Filaci G, Ferrone S, Indiveri F. Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes. Int Immunol 2000;12:195–203.

    Article  PubMed  CAS  Google Scholar 

  64. Puppo F, Ghio M, Contini P, Mazzei C, Indiveri F. Fas, Fas ligand, and transfusion immunomodulation. Transfusion 2001;41:416–418.

    Article  PubMed  CAS  Google Scholar 

  65. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeated hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003;238:703–710.

    Article  PubMed  Google Scholar 

  66. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, Kubota K, Zucchi A. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg. 1999;134:984–992.

    Article  PubMed  CAS  Google Scholar 

  67. Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999;229:322–330.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Jikei University School of Medicine, 3–25–8, Nishi-Shinbashi, Minato-ku, Tokyo, 105–8461, Japan

    Hiroaki Shiba, Yuichi Ishida, Shigeki Wakiyama, Tomonori Iida, Michinori Matsumoto, Taro Sakamoto, Ryusuke Ito, Takeshi Gocho, Kenei Furukawa, Yuki Fujiwara, Shoichi Hirohara, Takeyuki Misawa & Katsuhiko Yanaga

Authors
  1. Hiroaki Shiba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuichi Ishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shigeki Wakiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomonori Iida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michinori Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Taro Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ryusuke Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takeshi Gocho
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kenei Furukawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yuki Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Shoichi Hirohara
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Takeyuki Misawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Katsuhiko Yanaga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroaki Shiba.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shiba, H., Ishida, Y., Wakiyama, S. et al. Negative Impact of Blood Transfusion on Recurrence and Prognosis of Hepatocellular Carcinoma After Hepatic Resection. J Gastrointest Surg 13, 1636–1642 (2009). https://doi.org/10.1007/s11605-009-0963-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-009-0963-y

Keywords

Search

Navigation